COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial

JAMA. 2022 Jan 11;327(2):115. doi: 10.1001/jama.2021.24118.
No abstract available

Publication types

  • News

MeSH terms

  • Adjuvants, Vaccine
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / immunology*
  • Humans
  • T-Lymphocytes / immunology*

Substances

  • Adjuvants, Vaccine
  • COVID-19 Vaccines